Only psychiatrists who have been involved in psilocybin clinical trials will be allowed to prescribe it, and they must strictly report its use and keep detailed records.

Unfortunately, there’s only one such psychiatrist:

The psychiatrist, Cameron Lacey, who was behind the first clinical trials of psilocybin, has been identified as the only medical practitioner to prescribe the drug.

I agree with you completely. He’s fascinated with nukes, and believes naked demonstrations of power show that he’s strong. If he does drop a nuke in Iran, you can guarantee that Russia will use them in Ukraine, and that quickly opens the door to a much wider war in Europe. Strategic thinking is not Trump’s strong suit, and he’s likely to bumble us into a nuclear WWIII.

With Trump in the White House and Republicans controlling both houses of Congress, surely Trump will get his wall built, and then he’ll leverage tariffs to make Mexico pay for it, right? LOL.

This is really interesting. As I was reading the article I was wondering how they were going to wring money out of it, as amlodipine is off patent. Then I got to this part:

“While amlodipine shows promise in preclinical models, it is not currently suitable for use in ADHD in its marketed form,” Karlsson noted. “Further optimization through chemical modification is necessary to enhance CNS selectivity and ensure a favorable therapeutic index in the context of ADHD.”

Classic big pharma. Slightly tweak an existing drug in an insignificant way so that you can get a new patent on it and charge exorbitant prices.